Abstract
Synthetic cathinones have emerged in recreational drug markets as legal alternatives for classical amphetamines. Though currently banned in several countries, 3,4-methylenedioxypyrovalerone (MDPV) is one of the most commonly abused cathinone derivatives worldwide. We have recently reported the potential of MDPV to induce hepatocellular damage, but the underlying mechanisms responsible for such toxicity remain to be elucidated. Similar to amphetamines, a prominent toxic effect of acute intoxications by MDPV is hyperthermia. Therefore, the present in vitro study aimed to provide insights into cellular mechanisms involved in MDPV-induced hepatotoxicity and also evaluate the contribution of hyperthermia to the observed toxic effects. Primary cultures of rat hepatocytes were exposed to 0.2–1.6 mM MDPV for 48 h, at 37 or 40.5 °C, simulating the rise in body temperature that follows MDPV intake. Cell viability was measured through the MTT reduction and LDH leakage assays. Oxidative stress endpoints and cell death pathways were evaluated, namely the production of reactive oxygen and nitrogen species (ROS and RNS), intracellular levels of reduced (GSH) and oxidized (GSSG) glutathione, adenosine triphosphate (ATP) and free calcium (Ca2+), as well as the activities of caspases 3, 8 and 9, and nuclear morphological changes with Hoechst 33342/PI double staining. At 37 °C, MDPV induced a concentration-dependent loss of cell viability that was accompanied by GSH depletion, as one of the first signs of toxicity, observed already at low concentrations of MDPV, with negligible changes on GSSG levels, followed by accumulation of ROS and RNS, depletion of ATP contents and increases in intracellular Ca2+ concentrations. Additionally, activation of caspases 3, 8, and 9 and apoptotic nuclear morphological changes were found in primary rat hepatocytes exposed to MDPV, indicating that this cathinone derivative activates both intrinsic and extrinsic apoptotic death pathways. The cytotoxic potential of MDPV and all the studied endpoints were markedly aggravated under hyperthermic conditions (40.5 °C). In conclusion, these data suggest that MDPV toxicity in primary rat hepatocytes is mediated by oxidative stress, subsequent to GSH depletion and increased ROS and RNS accumulation, mitochondrial dysfunction, and impairment of Ca2+ homeostasis. Furthermore, the rise in body temperature subsequent to MDPV abuse greatly exacerbates its hepatotoxic potential.
Similar content being viewed by others
Abbreviations
- MDPV:
-
3,4-Methylenedioxypyrovalerone
- MDMA:
-
3,4-Methylenedioxymethamphetamine
- GSH:
-
Reduced glutathione
- GSSG:
-
Oxidized glutathione
- ROS:
-
Reactive oxygen species
- RNS:
-
Reactive nitrogen species
- ATP:
-
Adenosine triphosphate
References
Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA (2013) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71:130–140. doi:10.1016/j.neuropharm.2013.04.003
Adam A, Gerecsei LI, Lepesi N, Csillag A (2014) Apoptotic effects of the ‘designer drug’ methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain. Neurotoxicology 44:231–236. doi:10.1016/j.neuro.2014.07.004
Andreu V, Mas A, Bruguera M et al (1998) Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol 29(3):394–397
Araujo AM, Valente MJ, Carvalho M et al (2015) Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’ packages containing synthetic cathinones. Arch Toxicol. doi:10.1007/s00204-014-1278-7
Barbosa DJ, Capela JP, Silva R et al (2014) The mixture of “ecstasy” and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations. Arch Toxicol 88(2):455–473. doi:10.1007/s00204-013-1120-7
Baumgartner HK, Gerasimenko JV, Thorne C et al (2009) Calcium elevation in mitochondria is the main Ca2+ requirement for mitochondrial permeability transition pore (mPTP) opening. J Biol Chem 284(31):20796–20803. doi:10.1074/jbc.M109.025353
Beitia G, Cobreros A, Sainz L, Cenarruzabeitia E (1999) 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes. Liver 19(3):234–241
Beitia G, Cobreros A, Sainz L, Cenarruzabeitia E (2000) Ecstasy-induced toxicity in rat liver. Liver 20(1):8–15
Borek HA, Holstege CP (2012) Hyperthermia and multiorgan failure after abuse of “bath salts” containing 3,4-methylenedioxypyrovalerone. Ann Emerg Med 60(1):103–105. doi:10.1016/j.annemergmed.2012.01.005
Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS (2004) Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287(4):C817–C833. doi:10.1152/ajpcell.00139.2004
Capela JP, Ruscher K, Lautenschlager M et al (2006) Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience 139(3):1069–1081. doi:10.1016/j.neuroscience.2006.01.007
Capela JP, Macedo C, Branco PS et al (2007) Neurotoxicity mechanisms of thioether ecstasy metabolites. Neuroscience 146(4):1743–1757. doi:10.1016/j.neuroscience.2007.03.028
Carhart-Harris RL, King LA, Nutt DJ (2011) A web-based survey on mephedrone. Drug Alcohol Depend 118(1):19–22. doi:10.1016/j.drugalcdep.2011.02.011
Carvalho F, Remião F, Soares ME, Catarino R, Queiroz G, Bastos ML (1997) d-Amphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effect studied in isolated rat hepatocytes. Arch Toxicol 71(7):429–436
Carvalho M, Carvalho F, Bastos ML (2001) Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes. Arch Toxicol 74(12):789–793
Carvalho M, Milhazes N, Remiao F et al (2004) Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch Toxicol 78(1):16–24. doi:10.1007/s00204-003-0510-7
Carvalho M, Pontes H, Remiao F, Bastos ML, Carvalho F (2010) Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol 11(5):476–495
Carvalho M, Carmo H, Costa VM et al (2012) Toxicity of amphetamines: an update. Arch Toxicol 86(8):1167–1231. doi:10.1007/s00204-012-0815-5
Cerretani D, Bello S, Cantatore S et al (2011) Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFα-mediated apoptosis in rat liver. Pharmacol Res 64(5):517–527. doi:10.1016/j.phrs.2011.08.002
Coppola M, Mondola R (2012a) 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett 208(1):12–15. doi:10.1016/j.toxlet.2011.10.002
Coppola M, Mondola R (2012b) Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “plant food”. Toxicol Lett 211(2):144–149. doi:10.1016/j.toxlet.2012.03.009
De Letter EA, Piette MH, Lambert WE, Cordonnier JA (2006) Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976–2004. Med Sci Law 46(1):37–65
Deluca P, Schifano F, Davey Z, Corazza O, Di Furia L, Group PWMR (2009) MDPV report. http://www.psychonautproject.eu/
den Hollander B, Sundstrom M, Pelander A et al (2014) Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone. Toxicol Sci 141(1):120–131. doi:10.1093/toxsci/kfu108
da Silva DD, Carmo H, Lynch A, Silva E (2013) An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis. Arch Toxicol 87(12):2165–2185. doi:10.1007/s00204-013-1082-9
da Silva DD, Silva E, Carmo H (2014) Combination effects of amphetamines under hyperthermia—the role played by oxidative stress. J Appl Toxicol 34(6):637–650. doi:10.1002/jat.2889
Downey C, Daly F, O’Boyle KM (2014) An in vitro approach to assessing a potential drug interaction between MDMA (ecstasy) and caffeine. Toxicol In Vitro 28(2):231–239. doi:10.1016/j.tiv.2013.10.021
Duarte JA, Carvalho F, Natsis K et al (1999) Structural alterations of skeletal muscle induced by chronic administration of Damphetamine and food restriction. Basic Appl Myol 9(2):65-69
EMCDDA (2015) New psychoactive substances in Europe. An update from the EU Early Warning System. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. http://www.emcdda.europa.eu/. doi:10.2810/372415
EMCDDA-Europol (2014) EMCDDA—Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone). http://www.emcdda.europa.eu/. doi:10.2810/24085
Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC (2013) In vivo effects of abused ‘bath salt’ constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 38(4):563–573. doi:10.1038/npp.2012.233
Fröhlich S, Lambe E, O’Dea J (2011) Acute liver failure following recreational use of psychotropic “head shop” compounds. Ir J Med Sci 180(1):263–264. doi:10.1007/s11845-010-0636-6
Garcıa-Repetto R, Moreno E, Soriano T, Jurado C, Gimenez M, Menendez M (2003) Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose. Forensic Sci Int 135(2):110–114
Gatch MB, Taylor CM, Forster MJ (2013) Locomotor stimulant and discriminative stimulus effects of ‘bath salt’ cathinones. Behav Pharmacol 24(5–6):437–447. doi:10.1097/FBP.0b013e328364166d
German CL, Fleckenstein AE, Hanson GR (2014) Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci 97(1):2–8. doi:10.1016/j.lfs.2013.07.023
Halestrap AP (2006) Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 34(Pt 2):232–237. doi:10.1042/BST20060232
Halestrap AP (2009) What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46(6):821–831. doi:10.1016/j.yjmcc.2009.02.021
James D, Adams RD, Spears R et al (2011) Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emerg Med J 28(8):686–689. doi:10.1136/emj.2010.096636
Johnson PS, Johnson MW (2014) Investigation of “bath salts” use patterns within an online sample of users in the United States. J Psychoact Drugs 46(5):369–378. doi:10.1080/02791072.2014.962717
Jones S, Fileccia EL, Murphy M et al (2014) Cathinone increases body temperature, enhances locomotor activity, and induces striatal c-fos expression in the Siberian hamster. Neurosci Lett 559:34–38. doi:10.1016/j.neulet.2013.11.032
Kamijo Y, Soma K, Nishida M, Namera A, Ohwada T (2002) Acute liver failure following intravenous methamphetamine. Vet Hum Toxicol 44(4):216–217
Kanel GC, Cassidy W, Shuster L, Reynolds TB (1990) Cocaine-induced liver cell injury: comparison of morphological features in man and in experimental models. Hepatology 11(4):646–651
Kesha K, Boggs CL, Ripple MG et al (2013) Methylenedioxypyrovalerone (“bath salts”), related death: case report and review of the literature. J Forensic Sci 58(6):1654–1659. doi:10.1111/1556-4029.12202
Leier I, Jedlitschky G, Buchholz U et al (1996) ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J 314(Pt 2):433–437
Lopez-Arnau R, Martinez-Clemente J, Pubill D, Escubedo E, Camarasa J (2012) Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167(2):407–420. doi:10.1111/j.1476-5381.2012.01998.x
Lopez-Arnau R, Martinez-Clemente J, Rodrigo T, Pubill D, Camarasa J, Escubedo E (2015) Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone. Toxicol Appl Pharmacol. doi:10.1016/j.taap.2015.03.015
Marinetti LJ, Antonides HM (2013) Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. J Anal Toxicol 37(3):135–146. doi:10.1093/jat/bks136
McIlwain DR, Berger T, Mak TW (2013) Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 5(4):a008656. doi:10.1101/cshperspect.a008656
Meyer MR, Du P, Schuster F, Maurer HH (2010) Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC–MS and LC–high-resolution MS and its detectability in urine by GC–MS. J Mass Spectrom 45(12):1426–1442. doi:10.1002/jms.1859
Meyer MR, Richter LH, Maurer HH (2014) Methylenedioxy designer drugs: mass spectrometric characterization of their glutathione conjugates by means of liquid chromatography-high-resolution mass spectrometry/mass spectrometry and studies on their glutathionyl transferase inhibition potency. Anal Chim Acta 822:37–50. doi:10.1016/j.aca.2014.03.017
Miller ML, Creehan KM, Angrish D et al (2013) Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone). Drug Alcohol Depend 127(1–3):248–253. doi:10.1016/j.drugalcdep.2012.07.003
Mugele J, Nanagas KA, Tormoehlen LM (2012) Serotonin syndrome associated with MDPV use: a case report. Ann Emerg Med 60(1):100–102. doi:10.1016/j.annemergmed.2011.11.033
Murray BL, Murphy CM, Beuhler MC (2012) Death following recreational use of designer drug “bath salts” containing 3,4-methylenedioxypyrovalerone (MDPV). J Med Toxicol 8(1):69–75. doi:10.1007/s13181-011-0196-9
Penders TM, Gestring RE, Vilensky DA (2012) Excited delirium following use of synthetic cathinones (bath salts). Gen Hosp Psychiatry 34(6):647–650. doi:10.1016/j.genhosppsych.2012.06.005
Pontes H, Sousa C, Silva R et al (2008) Synergistic toxicity of ethanol and MDMA towards primary cultured rat hepatocytes. Toxicology 254(1–2):42–50. doi:10.1016/j.tox.2008.09.009
Shortall SE, Green AR, Swift KM, Fone KC, King MV (2013) Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia. Br J Pharmacol 168(4):966–977. doi:10.1111/j.1476-5381.2012.02236.x
Skibba JL, Stadnicka A, Kalbfleisch JH, Powers RH (1989) Effects of hyperthermia on xanthine oxidase activity and glutathione levels in the perfused rat liver. J Biochem Toxicol 4(2):119–125
Skibba JL, Powers RH, Stadnicka A, Cullinane DW, Almagro UA, Kalbfleisch JH (1991) Oxidative stress as a precursor to the irreversible hepatocellular injury caused by hyperthermia. Int J Hyperth 7(5):749–761
Strano-Rossi S, Cadwallader AB, de la Torre X, Botre F (2010) Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 24(18):2706–2714. doi:10.1002/rcm.4692
Tait SW, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11(9):621–632. doi:10.1038/nrm2952
Tsujimoto Y (2003) Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195(2):158–167. doi:10.1002/jcp.10254
Valente MJ, Henrique R, Vilas-Boas V et al (2012) Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells. Arch Toxicol 86(2):249–261. doi:10.1007/s00204-011-0749-3
Valente MJ, Guedes de Pinho P, de Lourdes BastosM, Carvalho F, Carvalho M (2014) Khat and synthetic cathinones: a review. Arch Toxicol 88(1):15–45. doi:10.1007/s00204-013-1163-9
Varner KJ, Daigle K, Weed PF et al (2013) Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats. Psychopharmacology 225(3):675–685. doi:10.1007/s00213-012-2855-1
Wills EJ, Findlay JM, McManus JP (1976) Effects of hyperthermia therapy on the liver. II. Morphological observations. J Clin Pathol 29(1):1–10
Wood DM, Davies S, Greene SL et al (2010) Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol 48(9):924–927. doi:10.3109/15563650.2010.531021
Wyman JF, Lavins ES, Engelhart D et al (2013) Postmortem tissue distribution of MDPV following lethal intoxication by “bath salts”. J Anal Toxicol 37(3):182–185. doi:10.1093/jat/bkt001
Zuba D, Byrska B (2013) Prevalence and co-existence of active components of ‘legal highs’. Drug Test Anal 5(6):420–429. doi:10.1002/dta.1365
Acknowledgments
M.J.V. thanks Fundação para a Ciência e Tecnologia (FCT), Portugal, for her PhD Grant (SFRH/BD/89879/2012). This work was supported by FCT, through the Project Pest-C/EQB/LA0006/2013.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Valente, M.J., Araújo, A.M., Silva, R. et al. 3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions. Arch Toxicol 90, 1959–1973 (2016). https://doi.org/10.1007/s00204-015-1653-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-015-1653-z